Capacity of developing country NRAs key to accelerated introduction of upcoming dengue vaccines
Tuesday, February 22, 2011 - 17:50
in Health & Medicine
At least one dengue vaccine could be licensed within the next 4 years, as manufacturers are speeding up the development process for multiple dengue vaccine candidates in collaboration with health authorities and developing countries to expedite the necessary testing, clinical trial design, and licensure, a team of leading scientists said.